The interactions and communications in tumor resistance to radiotherapy: Therapy perspectives DOI
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa

et al.

International Immunopharmacology, Journal Year: 2020, Volume and Issue: 87, P. 106807 - 106807

Published: July 16, 2020

Language: Английский

Radiotherapy combined with immunotherapy: the dawn of cancer treatment DOI Creative Commons

Zengfu Zhang,

Xu Liu,

Dawei Chen

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2022, Volume and Issue: 7(1)

Published: July 29, 2022

Abstract Radiotherapy (RT) is delivered for purposes of local control, but can also exert systemic effect on remote and non-irradiated tumor deposits, which called abscopal effect. The view RT as a simple treatment has dramatically changed in recent years, it now widely accepted that provoke immune response gives strong rationale the combination immunotherapy (iRT). Nevertheless, several points remain to be addressed such interaction system, identification best schedules with (IO), expansion mechanism amplify iRT. To answer these crucial questions, we roundly summarize underlying showing whole landscape clinical trials attempt identify In consideration rarity effect, propose occurrence induced by radiation promoted 100% molecular genetic level. Furthermore, “radscopal effect” refers using low-dose reprogram microenvironment may overcome resistance Taken together, could regarded trigger antitumor response, help IO used radical added into current standard regimen patients metastatic cancer.

Language: Английский

Citations

359

Immunomodulation by radiotherapy in tumour control and normal tissue toxicity DOI
Urszula Cytlak, Douglas P. Dyer, Jamie Honeychurch

et al.

Nature reviews. Immunology, Journal Year: 2021, Volume and Issue: 22(2), P. 124 - 138

Published: July 1, 2021

Language: Английский

Citations

160

Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances DOI Creative Commons

Zuxiang Yu,

Chaoyu Xu,

Bin Song

et al.

Journal of Translational Medicine, Journal Year: 2023, Volume and Issue: 21(1)

Published: Oct. 9, 2023

Abstract Cancer remains the leading cause of death around world. In cancer treatment, over 50% patients receive radiotherapy alone or in multimodal combinations with other therapies. One adverse consequences after radiation exposure is occurrence radiation-induced tissue fibrosis (RIF), which characterized by abnormal activation myofibroblasts and excessive accumulation extracellular matrix. This phenotype can manifest multiple organs, such as lung, skin, liver kidney. In-depth studies on mechanisms have shown that a variety signals immune cells release cytokines, intracellular cGAS/STING, oxidative stress response, metabolic reprogramming proteasome pathway are involved myofibroblasts. Tissue extremely harmful to patients' health requires early diagnosis. addition traditional serum markers, histologic imaging tests, diagnostic potential nuclear medicine techniques emerging. Anti-inflammatory antioxidant therapies treatments for fibrosis. Recently, some promising therapeutic strategies emerged, stem cell therapy targeted However, incomplete knowledge hinders treatment this disease. Here, we also highlight mechanistic, directions

Language: Английский

Citations

51

Radiotherapy and immunology DOI Creative Commons
Liangliang Wang, Connor Lynch, Sean P. Pitroda

et al.

The Journal of Experimental Medicine, Journal Year: 2024, Volume and Issue: 221(7)

Published: May 21, 2024

The majority of cancer patients receive radiotherapy during the course treatment, delivered with curative intent for local tumor control or as part a multimodality regimen aimed at eliminating distant metastasis. A major focus research has been DNA damage; however, in past two decades, emphasis shifted to important role immune system plays radiotherapy-induced anti-tumor effects. Radiotherapy reprograms microenvironment, triggering and RNA sensing cascades that activate innate immunity ultimately enhance adaptive immunity. In opposition, also induces suppression immunity, including recruitment regulatory T cells, myeloid-derived suppressor suppressive macrophages. balance pro- is regulated by chemokines cytokines. Microbiota can influence outcomes under clinical investigation. Blockade PD-1/PD-L1 axis CTLA-4 extensively investigated combination radiotherapy; we include review trials involving inhibition these checkpoints radiotherapy.

Language: Английский

Citations

26

Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics DOI
Zhaoyi Ye, Ying Bao, Zefeng Chen

et al.

Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 504, P. 215654 - 215654

Published: Jan. 20, 2024

Language: Английский

Citations

19

FLASH radiotherapy: A new milestone in the field of cancer radiotherapy DOI
Rui Tang,

Jianqiong Yin,

Yuanxin Liu

et al.

Cancer Letters, Journal Year: 2024, Volume and Issue: 587, P. 216651 - 216651

Published: Feb. 10, 2024

Language: Английский

Citations

19

Abscopal effect in radioimmunotherapy DOI
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa

et al.

International Immunopharmacology, Journal Year: 2020, Volume and Issue: 85, P. 106663 - 106663

Published: June 7, 2020

Language: Английский

Citations

112

Damage-associated molecular patterns in tumor radiotherapy DOI
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa

et al.

International Immunopharmacology, Journal Year: 2020, Volume and Issue: 86, P. 106761 - 106761

Published: July 3, 2020

Language: Английский

Citations

98

Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives DOI
Keywan Mortezaee, Masoud Najafi

Critical Reviews in Oncology/Hematology, Journal Year: 2020, Volume and Issue: 157, P. 103180 - 103180

Published: Nov. 16, 2020

Language: Английский

Citations

92

Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer DOI Creative Commons
Milad Ashrafizadeh,

Mohammad Reza Bakhoda,

Zahra Bahmanpour

et al.

Frontiers in Chemistry, Journal Year: 2020, Volume and Issue: 8

Published: Oct. 15, 2020

Pancreatic cancer is the most lethal malignancy of gastrointestinal tract. Because its propensity for early local and distant spread, affected patients possess extremely poor prognosis. Currently applied treatments are not effective enough to eradicate all cells, minimize their migration. Besides, these associated with adverse effects on normal cells organs. These therapies able increase overall survival rate patients; hence, finding novel adjuvants or alternatives so essential. Up now, medicinal herbs were utilized therapeutic goals. Herbal-based medicine, as traditional biotherapeutics, was employed treatment. Of them, apigenin, a bioactive flavonoid that possesses numerous biological properties (e.g., anti-inflammatory anti-oxidant effects), has shown substantial anticancer activity. It seems apigenin capable suppressing proliferation via induction cell cycle arrest apoptosis. inhibits metastasis down-regulation matrix metalloproteinases Akt signaling pathway. In pancreatic sensitizes into chemotherapy, affects molecular pathways such hypoxia inducible factor (HIF), vascular endothelial growth (VEGF), glucose transporter-1 (GLUT-1), etc. Herein, biotherapeutic activity mechanisms toward presented in current review shed some light anti-tumor different cancers, an emphasis cancer.

Language: Английский

Citations

91